Kamran Mansouri
Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran
[ 1 ] - Dopamine-conjugated apoferritin protein nanocage for the dual-targeting delivery of epirubicin
Objective(s): Nanocarriers are drug delivery vehicles, which have attracted the attention of researchers in recent years, particularly in cancer treatment. The encapsulation of anticancer drugs using protein nanocages is considered to be an optimal approach to reducing drug side-effects and increasing the bioavailability of anticancer drugs. Epirubicin (EPR) is an active chemotherapeutic medica...
[ 2 ] - Coexistence of BCR-ABL1 Translocation and JAK2 V617F Mutation in a Patient with Chronic Myeloid Leukemia Under Long-term Treatment with Imatinib and Nilotinib: A Case Report
This report describes an 89-year-old woman diagnosed with Philadelphia positive Chronic Myeloid Leukemia in 2007 who was initially treated with 200 mg/day imatinib. The patient demonstrated complete molecular response (CMR) in two tests in 2015 and 2018. During treatment between 2007 and 2019, despite increased dosage of imatinib and switching her therapy to nilotinib, complete hematological r...
[ 3 ] - Difference in the Cytomegalovirus-related clinical laboratory findings between patients with bone marrow and kidney transplantation
Background: Despite close monitoring of transplant patients, cytomegalovirus (CMV) infection remains one of the most critical problems in the field of transplantation. This study aims to investigate the relationship between CMV viral load and clinical laboratory findings in transplant recipients. Materials And Methods: Thirty-four transplant recipients comprising 15 kidney transplant (KT) reci...
Co-Authors